John B. Whelan
Chief Executive Officer presso Inhalon Biopharma, Inc.
Profilo
John B.
Whelan is currently the President, Chief Executive Officer & Director at Inhalon Biopharma, Inc. and a Director at DxUpClose, Inc. He previously worked as the Director-Corporate Development at HP, Inc. and held various Principal positions at Biogen MA, Inc., Medarex, Inc., ICOS Corp., and Seagen Inc. He was also the Chief Financial Officer at Heron Therapeutics, Inc. and the President & Chief Operating Officer at Neuraltus Pharmaceuticals, Inc. Additionally, he served as the Chief Operating & Financial Officer at Raven Biotechnologies, Inc. and the Chief Financial Officer & Vice President at EOS Biotechnology, Inc. Mr. Whelan holds an MBA degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di John B. Whelan
| Società | Posizione | Inizio |
|---|---|---|
DxUpClose, Inc.
 DxUpClose, Inc. Miscellaneous Commercial ServicesCommercial Services DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX. | Director/Board Member | - |
Inhalon Biopharma, Inc.
 Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | Chief Executive Officer | 01/03/2019 |
Precedenti posizioni note di John B. Whelan
| Società | Posizione | Fine |
|---|---|---|
| HERON THERAPEUTICS, INC. | President | 02/05/2013 |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 01/07/2008 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Director of Finance/CFO | 01/03/2002 |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | President | - |
| HP INC. | Corporate Officer/Principal | - |
Formazione di John B. Whelan
| University of California, Los Angeles | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| HP INC. | Electronic Technology |
| Aziende private | 9 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
Neuraltus Pharmaceuticals, Inc.
Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Health Technology |
DxUpClose, Inc.
DxUpClose, Inc. Miscellaneous Commercial ServicesCommercial Services DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX. | Commercial Services |
Inhalon Biopharma, Inc.
Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | Health Technology |
- Borsa valori
- Insiders
- John B. Whelan
